Imatinib para-diaminomethylbenzene

CAS: 1026753-54-7

Ref. 3D-BRB75354

Produktinformation

• Name: Imatinib para-diaminomethylbenzene

Beschreibung

Imatinib is a kinase inhibitor that inhibits the kinase activity of tyrosine-protein phosphatase receptor (c-Abl) and platelet-derived growth factor receptor (PDGFR), which are both involved in tumor cell proliferation. Imatinib has been shown to be effective in treating leukemia and other types of cancer, as well as regulating the production of cytokines and protein tyrosine phosphatases. It is also being studied for use in Alzheimer's disease. Imatinib has selectivity for c-Abl over PDGFR, which makes it an attractive drug candidate for cancer therapy.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 493.6 g/mol
• Formel: C₂₉H₃₁N₇O
• Reinheit: Min. 95%